lnfliximab dose intensification in 17-years old patients with Crohn's disease

Abstract

nfliximab is recommended for the treatment of sever, active Crohn's disease (CD) in pediatrie and adolescent patients, who have not responded to conventional therapy. Case report of 17-years old boy with celiac disease and sever CD (A1, L3+L4, B3p) diagnosed at ten ye-ars of age is presented. During the third year of maintenance therapy he lost response to interval of infliximabu infusion. Clinical response was regained after dose intensification by decreasing in interval from eight to four weeks between infliximab infusions. After three months of the intensive treatment with infliximab, patient still remains in clinical remission.

Authors and Affiliations

Małgorzata Sładek

Keywords

Related Articles

Carnitine deficiency and effectiveness of oral carnitine supplementation in children with short bowel syndrome

Introduction: Carnitine is necessary for the transfer of fatty acids across the inner mitochondrial membrane for oxydation metabolism. Aim of study: The aim of the study was to analyze serum carnitine concentration in ch...

Should specimens be collected on gastrofiberoscopy for histological evaluation in children?

Introduction: A lot of practitioners express their doubts as to the necessity of gastric mucosa histological examination sińce Helicobacter pylori(H. pylori) eradication therapy without histological evaluation is also ap...

Ogólnopolskie badanie nad zawartością wapnia i witaminy D w dietach dzieci w wieku 4 lat

Wyniki ogólnopolskich badań żywieniowych przeprowadzonych w 2005 r. na reprezentatywnej grupie czterolatków potwierdziły niedobory wapnia i witaminy D w dietach dzieci. Niedobory te mają charakter przewlekły i mogą być t...

Obraz kliniczny nieswoistych zapaleń jelit u dzieci do 5 roku życia - obserwacje własne

Wprowadzenie: W ostatnich latach obserwuje się wzrost zachorowań na nieswoiste zapalenia jelit (n.z.j.) we wszystkich grupach wiekowych, w tym także u najmłodszych dzieci, u których przebieg choroby jest wciąż mało pozna...

Atypical celiac disease in riskgroup in children

Introduction: During last 20 years clinical course of celiac disease changed mostly into atypical, often with clinical manifestation outside of the gastrointestinal tract. Objectives: The aim of the study was to evaluate...

Download PDF file
  • EP ID EP82767
  • DOI -
  • Views 108
  • Downloads 0

How To Cite

Małgorzata Sładek (2007). lnfliximab dose intensification in 17-years old patients with Crohn's disease. Pediatria Współczesna. Gastroenterologia, Hepatologia i Żywienie Dziecka, 9(3), 219-220. https://europub.co.uk/articles/-A-82767